What Researchers Did
This study investigated the in vitro effects of human hyperbaric oxygen treatment protocols on the growth and survival of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans, and their sensitivity to antibiotics.
What They Found
Researchers found no significant differences in the growth curves of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans between control and hyperbaric oxygen-treated groups. Furthermore, hyperbaric oxygen treatment protocols did not produce any measurable difference in the bactericidal effectiveness of selected antibiotics.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy, when administered using typical human treatment protocols, may not directly inhibit the growth of common bacteria and yeast or enhance antibiotic efficacy. Patients undergoing hyperbaric oxygen therapy should not expect a direct antimicrobial effect from the treatment itself against these specific pathogens.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is its in vitro design, which may not fully reflect the complex biological environment within a living organism.